Dill-Macky A S, Lee E N, Wertheim J A, Koss K M
Department of Surgery, University of Arizona, 1501 N Campbell Ave, Tucson, AZ 85724, United States.
Department of Neurobiology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-0625, United States; Sealy Institute for Drug Discovery, University of Texas Medical Branch, 105 11th Street Galveston, TX 77555-1110, United States.
Acta Biomater. 2024 Dec;190:24-49. doi: 10.1016/j.actbio.2024.10.017. Epub 2024 Oct 11.
Glia are imperative in nearly every function of the nervous system, including neurotransmission, neuronal repair, development, immunity, and myelination. Recently, the reparative roles of glia in the central and peripheral nervous systems have been elucidated, suggesting a tremendous potential for these cells as novel treatments to central nervous system disorders. Glial cells often behave as 'double-edged swords' in neuroinflammation, ultimately deciding the life or death of resident cells. Compared to glia, neuronal cells have limited mobility, lack the ability to divide and self-renew, and are generally more delicate. Glia have been candidates for therapeutic use in many successful grafting studies, which have been largely focused on restoring myelin with Schwann cells, olfactory ensheathing glia, and oligodendrocytes with support from astrocytes. However, few therapeutics of this class have succeeded past clinical trials. Several tools and materials are being developed to understand and re-engineer these grafting concepts for greater success, such as extra cellular matrix-based scaffolds, bioactive peptides, biomolecular delivery systems, biomolecular discovery for neuroinflammatory mediation, composite microstructures such as artificial channels for cell trafficking, and graft enhanced electrical stimulation. Furthermore, advances in stem cell-derived cortical/cerebral organoid differentiation protocols have allowed for the generation of patient-derived glia comparable to those acquired from tissues requiring highly invasive procedures or are otherwise inaccessible. However, research on bioengineered tools that manipulate glial cells is nowhere near as comprehensive as that for systems of neurons and neural stem cells. This article explores the therapeutic potential of glia in transplantation with an emphasis on novel bioengineered tools for enhancement of their reparative properties. STATEMENT OF SIGNIFICANCE: Neural glia are responsible for a host of developmental, homeostatic, and reparative roles in the central nervous system but are often a major cause of tissue damage and cellular loss in insults and degenerative pathologies. Most glial grafts have employed Schwann cells for remyelination, but other glial with novel biomaterials have been employed, emphasizing their diverse functionality. Promising strategies have emerged, including neuroimmune mediation of glial scar tissues and facilitated migration and differentiation of stem cells for neural replacement. Herein, a comprehensive review of biomaterial tools for glia in transplantation is presented, highlighting Schwann cells, astrocytes, olfactory ensheating glia, oligodendrocytes, microglia, and ependymal cells.
神经胶质细胞在神经系统的几乎每一项功能中都至关重要,包括神经传递、神经元修复、发育、免疫和髓鞘形成。最近,神经胶质细胞在中枢和外周神经系统中的修复作用已得到阐明,这表明这些细胞作为治疗中枢神经系统疾病的新方法具有巨大潜力。在神经炎症中,神经胶质细胞往往表现为“双刃剑”,最终决定驻留细胞的生死。与神经胶质细胞相比,神经元细胞移动性有限,缺乏分裂和自我更新的能力,而且通常更为脆弱。在许多成功的移植研究中,神经胶质细胞一直是治疗用途的候选对象,这些研究主要集中在利用雪旺细胞、嗅鞘胶质细胞和少突胶质细胞在星形胶质细胞的支持下恢复髓鞘形成。然而,这类治疗方法很少能成功通过临床试验。目前正在开发几种工具和材料,以理解并重新设计这些移植概念以取得更大成功,例如基于细胞外基质的支架、生物活性肽、生物分子递送系统、用于神经炎症调节的生物分子发现、复合微结构(如用于细胞运输的人工通道)以及移植增强电刺激。此外,干细胞衍生的皮质/脑类器官分化方案的进展使得能够生成与从需要高侵入性程序获取或无法获取的组织中获得的神经胶质细胞相当的患者来源的神经胶质细胞。然而,关于操纵神经胶质细胞的生物工程工具的研究远不如对神经元和神经干细胞系统的研究全面。本文探讨了神经胶质细胞在移植中的治疗潜力,重点介绍了用于增强其修复特性的新型生物工程工具。重要性声明:神经胶质细胞在中枢神经系统中负责一系列发育、稳态和修复作用,但在损伤和退行性病变中往往是组织损伤和细胞损失的主要原因。大多数神经胶质细胞移植采用雪旺细胞进行髓鞘再生,但也采用了其他带有新型生物材料的神经胶质细胞,强调了它们的多样功能。已经出现了一些有前景的策略,包括神经胶质瘢痕组织的神经免疫调节以及促进干细胞迁移和分化以进行神经替代。本文全面综述了用于移植的神经胶质细胞的生物材料工具,重点介绍了雪旺细胞、星形胶质细胞、嗅鞘胶质细胞、少突胶质细胞、小胶质细胞和室管膜细胞。